Summit Trail Advisors, LLC Galera Therapeutics, Inc. Transaction History
Summit Trail Advisors, LLC
- $3.71 Billion
- Q1 2024
A detailed history of Summit Trail Advisors, LLC transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 147,658 shares of GRTX stock, worth $20,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,658Holding current value
$20,672% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GRTX
# of Institutions
38Shares Held
10.7MCall Options Held
10.3KPut Options Held
0-
Gsa Capital Partners LLP London, X03.63MShares$508,5670.04% of portfolio
-
Blackstone Inc New York, NY1.68MShares$235,0570.0% of portfolio
-
Abrdn PLC898KShares$125,7720.0% of portfolio
-
Tekla Capital Management LLC898KShares$125,7720.11% of portfolio
-
Nan Fung Group Holdings LTD Central, K3613KShares$85,8510.08% of portfolio
About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $3.76M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...